Northern England Strategic Clinical Network Conference 15 th May 2015 Haemosys System David Bottoms Diagnostic Project Manager.

Slides:

Advertisements

Similar presentations

Integrated Care Records David Hancorn & Julia Hopper HealthSystems Consultants Ltd Research & Practice Workshop Edinburgh, 11th/12.

Advertisements

Cancer Registration and Health Service Regulation Dr Jenifer A E Smith.

The Diagnostic Laboratory ……the ideal system……. Molecular Genetics Diagnostic Laboratory Exciting area of medical pathology Need to continually up-date.

UK Clinical Research Network (UKCRN) UK Clinical Research Network Maxine Stead PhD UKCRN Assistant Director – Clinical Trials.

NICE and National Clinical Audit Participating Trust Perspective Jean Schofield Clinical Audit Development Manager.

Northern & Yorkshire Cancer Registry & Information Service NHS UKACR Conference 30 September How useful is the Cancer Waiting Times (CWT) dataset.

The Lancashire and South Cumbria Cancer Network Dr Russell Thorpe PCCL Dr David Elliott PCCL.

Standardising Chemotherapy Nursing Practice across a Cancer Network Claire Kelly Network Lead Nurse Cancer Care Alliance of Teesside, South Durham & North.

BabyClear Implementing a regional approach to tackling smoking in pregnancy Martyn Willmore Performance Improvement Delivery Manager, Fresh Hilary Wareing.

Registries, Databases & Clinical Networks David J Burn Newcastle University.

Taxanes for Ovarian Cancer: Progress Report Rosemary Tate Information Projects Team December 2000.

The challenges of coding cancer of unknown primary A survey of registration and reporting practices in the UK, Ireland and Australia Claudia Oehler 1,

Cancer Summit Plymouth Hospitals NHS Trust 12 th February 2015 Ruth Bridgeman - Programme Director, National Peer Review Programme.

The National Cancer Intelligence Network An overview Professor David Forman Professor of Cancer Epidemiology, University of Leeds NCIN – Lead for Information.

Children and Young People Improving Outcomes Guidance  Key aims of guidance and age specific requirements  Designation of Principal Treatment Centres.

Guidance on Cancer Services Improving Outcomes for People with Skin Tumours including Melanoma NICE Stateholder Consultation version July 2005.

Northern England Strategic Clinical Network Conference 15 th May 2015 The Northern Children’s Surgical Network Gareth Hosie.

1 The UK Opportunity: what is experimental medicine? UNLOCK YOUR GLOBAL BUSINESS POTENTIAL Pre- clinical development Phase I Phase II Phase III Product.

Healthcare in the UK Margaret Costello – Gorlin Syndrome Group.

Research-driven data standards CIMI 11 th April 2013.

Audit of EGFR mutation testing in patients with proven Non-Small Cell Lung Cancer On behalf of the North of England Cancer Network Lung NSSG Dr Naomi Chamberlin,

Northern England Strategic Clinical Network Conference 15 th May 2015 Diabetes Update Rahul Nayar.

South East Wales Critical Care Network Challenges Ahead.

North East Paediatric Audiology Network Update 25 September 2014 Ed Brown Consultant Clinical Scientist Local Director NHSP Sunderland Royal Hospital

Implementing universal Lynch Syndrome screening in a large healthcare system.

The Cancer Control Programme in England Lindsay Wilkinson Head of Cancer Policy Team – Department of Health (England)

100k Genomes Project In December 2012 the Prime Minister announced a programme of Whole Genome Sequencing as part of the UK Government’s Life Sciences.

Northern England Strategic Clinical Network Conference 15 th May 2015 Dementia Update Dr Louise Allan Clinical lead for dementia.

Northern England Strategic Clinical Network Conference 15 th May 2015 Vascular Update Professor Gerard Stansby Newcastle upon Tyne

Information Projects TeamThyroid Cancer March 2001 Taxanes for Ovarian Cancer: Progress Report Rosemary Tate Projects Co-ordinator January 2001.

April 2005 How Patients Can Benefit From Molecular Imaging Paula M. Jacobs, Ph.D Vice President Advanced Magnetics, Inc.

May 2001 Management of Thyroid Cancer Information Projects Team THE MANAGEMENT OF PATIENTS WITH THYROID CANCER Cathy Bennett Information Projects Manager.

PUTTING THE PIECES TOGETHER. Overview Sharing information.

Haematology Dr Victoria Hervey Chair Haematology NSSG North of England Cancer Network Annual Conference 20 September 2013.

National Cancer Intelligence Network data usage 17 November 2015 – Veronique Poirier – Principal Cancer Analyst – NCIN.

Technical Support to SOA Governance E-Government Conference May 1-2, 2008 John Salasin, Ph.D. DARPA

100k Genomes Project Programme of Whole Genome Sequencing, part of UK Life Sciences Strategy Aim to sequence 100,000 genomes from patients with cancer.

I’m not just a child. I’m a daughter. I’m a son. I’m also a friend, a parent, a wife, a husband…

Improving Cancer Outcomes in Camden Dr Lucia Grun 19 March 2014.

Dr Heather O Dickinson My web page Department of Child Health University of Newcastle My web page Audit of cancer registrations notified by National Health.

PathoSys ® NEPath Project Update 6 th September 2011.

Out of hours audit Jane Arthur Cancer Nursing Modernisation Manager NECN 26 th January 2011.

UNM Virtual Human Biospecimen Repository -- Pitfalls and the Possibilities UNM Biocomputing Conference April 22, 2005 Philip J. Kroth, M.D., M.S.

Northern Region Colorectal Liver Metastases Study Guru Raghavendra.

Diagnostic Review Board Presented by Dr Peter Holloway & Dr Karen Blades 15 th October

Northern Training Consortium Update Andy Knight. NOTE This is an update – so everyone knows what is going on – rather than seeking approval from the subgroup.

The management of low-risk basal cell carcinomas in the community Implementing NICE guidance in general practice May 2010 NICE guidance on cancer services.

Implementing NICE guidance on autism – developing a local autism team January 2014 Autism: the management and support of children and young people on the.

The Cancer Registry of Norway Jan F Nygård Head of the IT-department.

Midland Cancer Network 2012 Clinical Performance Conference.

Training for organisations participating in Peer Review of Paediatric Diabetes.

Haematology and Blood Transfusion STP post Blood Sciences Newcastle Upon Tyne Hospitals NHS Foundation Trust (NUTH)

Haematological malignancy research network © April 2014.

RARE SKIN TUMOURS IN THE SOUTH WEST J Weeks, V Poirier, J Verne, C Harling on behalf of the Skin Cancer Tumour Panel Objective NICE Improving Outcomes.

TRIAL PARTICIPATION IN THE OVER 60s: A RE-AUDIT OF THE MANAGEMENT OF AML IN THE SOUTH WEST OF ENGLAND South West Cancer Intelligence Service

NORTHUMBRIA PANCREATIC CARCINOMAS – Jan 2013 – Jan 2014 Number of new pancreatic carcinoma referrals56 Number of case discussed in local MDT55 Number of.

Methods Three questionnaires were designed with reference to national guidelines and the PCRMP’s recommendations. These questionnaires were sent to PCTs,

Diabetes Research Network Professor Azeem Majeed Imperial College, London.

SWAG SSG Lung Cancer Meeting

The Role of LIMS in Improving Laboratory services at NPHL, Kenya

An Approach to Standard Programming in a Clinical Data Repository

Making MDTs better Steve Falk

100,000 Genomes Project & Mainstreaming Genomic Medicine

Mainstreaming Genomic Medicine post 100,000 Genomes Project

Haematology SSG 7th November 2018

2018 National Mesothelioma Audit

Haematological malignancies – creating new clinical pathways for WGS

Regional Melanoma & Complex Skin Cancer Meeting

SWAG SSG Haematology and Lymphoma Cancer Meeting

Regional SIHMDS Update

Presentation transcript:

Northern England Strategic Clinical Network Conference 15 th May 2015 Haemosys System David Bottoms Diagnostic Project Manager

What is the Haemosys System ? A central information repository for the region’s Leukaemia and Lymphoma patients IT system hosted by Newcastle, commercially supported and developed Linked to all regional FTs and their LIMS systems A web-system so accessible from Leeds Cancer Registry

Why was it required ? NICE’s ‘Improving Outcomes in Haematological Cancers (IOG)’ published in National Peer Review Standards for Haematological Cancers (sections 1C-120 to 1C-12). Specialist Integrated Haematological Malignancy Diagnostic Services (SIHMDS) should cover a catchment population of at least 2 million Consistency and accuracy of diagnosis Single integrated report (marrows, flow cell analysis, genetics) No duplications Integrated Diagnostic Pathways Provision of WHO/ ICD codes Provide Clinical Audit/ Key Performance Indicators (ie TRTs)

Progress Report – May 2015 Haemosys System installed into Newcastle and linked to all FTs System configured/ tested/ developed/ diagnostic pathways agreed Staff training at Newcastle, S Tees and Nbria System Live – Newcastle cases since Jan, all regional cases since April – over 300 cases now in system Interfaced to LIMS at Newcastle/ S Tees Interface testing in process at Co Durham, Gateshead, Nbria, N Cumbria Links with NYCRIS in process

This is it !

Benefits All Trusts are now receiving single integrated reports All reporting now meets IOG guidance Attachments/ images can be stored with the cases Clinical Audit Trials have commenced Direct analysis by NYCRIS will be available shortly Improved audit trails/ specimen tracking Quality improvements / standardisation of reporting Links with Biobanking/ Clinical Trials

Lessons learnt/ Issues LIMS Interface testing has been time consuming Integration with remote FT sample taking processes has taken time to plan/ engineer Overall it is a time-saver